Below are the financial statements of Procept Biorobotics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 224.5a | 136.19a | 75.01a |
| Cost of sales | -87.4a | -65.14a | -37.93a |
| Gross profit | 137.1a | 71.05a | 37.09a |
| Operating expenses | — | — | — |
| Research and development | -62.3a | -48.45a | -28.98a |
| Selling, general and administrative | -171.42a | -131.77a | -88.83a |
| Total operating expenses | -233.71a | -180.22a | -117.81a |
| Loss from operations | -96.61a | -109.17a | -80.72a |
| Interest expense | -4.18a | -4a | -5.18a |
| Interest and other income, net | 9.39a | 7.27a | 2.01a |
| Loss on loan extinguishment | 0a | 0a | -3.26a |
| Net loss | -91.41a | -105.9a | -87.15a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Procept Biorobotics’s data sources below and access millions more through our Disclosure Search.